Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magda Melchert

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Oncology (Williston Park, N.Y.)|December 21, 2006
Managing acute myeloid leukemia in the elderlyMagda Melchert
The International Journal of Biochemistry & Cell Biology|March 21, 2007
The thalidomide sagaMagda Melchert, Alan List
Seminars in Hematology|January 9, 2008
Targeted therapies in myelodysplastic syndromeMagda Melchert, Alan List
Hematology. American Society of Hematology. Education Program|November 21, 2007
Management of RBC-transfusion dependenceMagda Melchert, Alan F List
Current Opinion in Hematology|January 27, 2007
The role of lenalidomide in the treatment of patients with chromosome 5q deletion and other myelodysplastic syndromesMagda Melchert, Vishakha Kale, Alan List
American Journal of Hematology|June 20, 2015
A multicenter, phase II study of maintenance azacitidine in older patients with acute myeloid leukemia in complete remission after induction chemotherapyPatrick T Griffin, Rami S Komrokji, Carlos M De Castro, et al.
Blood|April 29, 2009
Phase 1 multicenter dose-escalation study of ezatiostat hydrochloride (TLK199 tablets), a novel glutathione analog prodrug, in patients with myelodysplastic syndromeAzra Raza, Naomi Galili, Scott Smith, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Oncology (Williston Park, N.Y.)|December 21, 2006
Managing acute myeloid leukemia in the elderlyMagda Melchert
The International Journal of Biochemistry & Cell Biology|March 21, 2007
The thalidomide sagaMagda Melchert, Alan List
Seminars in Hematology|January 9, 2008
Targeted therapies in myelodysplastic syndromeMagda Melchert, Alan List
Hematology. American Society of Hematology. Education Program|November 21, 2007
Management of RBC-transfusion dependenceMagda Melchert, Alan F List
Current Opinion in Hematology|January 27, 2007
The role of lenalidomide in the treatment of patients with chromosome 5q deletion and other myelodysplastic syndromesMagda Melchert, Vishakha Kale, Alan List
American Journal of Hematology|June 20, 2015
A multicenter, phase II study of maintenance azacitidine in older patients with acute myeloid leukemia in complete remission after induction chemotherapyPatrick T Griffin, Rami S Komrokji, Carlos M De Castro, et al.
Blood|April 29, 2009
Phase 1 multicenter dose-escalation study of ezatiostat hydrochloride (TLK199 tablets), a novel glutathione analog prodrug, in patients with myelodysplastic syndromeAzra Raza, Naomi Galili, Scott Smith, et al.
Pageof 1